103 related articles for article (PubMed ID: 6827163)
1. [Gynecological cancer and ferritin--a study on the carcinofetoplacental ferritin].
Kobayashi H; Sakura H; Mizutani S
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):47-52. PubMed ID: 6827163
[TBL] [Abstract][Full Text] [Related]
2. [Ferritin levels in patients with cervical squamous cell carcinoma (author's transl)].
Nomiyama H
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):245-9. PubMed ID: 7234335
[TBL] [Abstract][Full Text] [Related]
3. [Ferritin study in tumors of the female genitalia].
Borisenko SA; Prokopenko PG; Makarov OV
Vopr Onkol; 1983; 29(6):45-8. PubMed ID: 6408801
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of serum ferritin in female genital neoplasms].
Dong MY
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
[TBL] [Abstract][Full Text] [Related]
5. [Serum ferritin and trophoblastic globulin in genital tumors in women].
Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
[TBL] [Abstract][Full Text] [Related]
6. [Serum ferritin levels in patient with gynecological malignancy--especially the judgement of therapeutic response and the monitor during the post-therapeutic follow-up period (author's transl)].
Washizuka N; Yamazaki T; Shimizu T; Kikuchi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1695-702. PubMed ID: 7310197
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum ferritin levels in urologic cancer (II)].
Washida H; Fushimi N; Tsugaya M
Hinyokika Kiyo; 1983 Jan; 29(1):17-22. PubMed ID: 6677086
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
9. [Ferritin levels of ascites and the contents of cystic ovarian tumors--possibilities of ferritin production and secretion by malignant tumor cells].
Okamoto M; Fukasawa H; Hirata F; Hoshi S
Gan To Kagaku Ryoho; 1984 Feb; 11(2):240-6. PubMed ID: 6696460
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
[TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies.
Moroz C; Bessler H; Lurie Y; Shaklai M
Exp Hematol; 1987 Mar; 15(3):258-62. PubMed ID: 3817052
[TBL] [Abstract][Full Text] [Related]
12. [The significance of serum leucine aminopeptidase (P-LAP) determination in the gynecological malignancies].
Kobayashi H; Sakura H; Kurauchi O; Mizutani S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):696-702. PubMed ID: 2582069
[TBL] [Abstract][Full Text] [Related]
13. [Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)].
Sekiya S; Kawata M; Inaba N; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):37-42. PubMed ID: 6174649
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of serum ferritin levels in the assessment of iron status in non-pregnant Zairean women of childbearing age.
Kuvibidila S; Yu L; Warrier RP; Ode D; Mbele V
J Trop Med Hyg; 1994 Jun; 97(3):171-9. PubMed ID: 8007058
[TBL] [Abstract][Full Text] [Related]
16. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation on serum ferritin in gynecological diseases with special attention to uterine cancer (author's transl)].
Ishikawa K; Narita O; Fujita M; Hayashi D; Saito H
Rinsho Ketsueki; 1982 Feb; 23(2):129-37. PubMed ID: 7098007
[No Abstract] [Full Text] [Related]
18. Immunohistochemical basic and acidic isoferritins in hepatocellular carcinoma.
Cohen C
Mod Pathol; 1988 Nov; 1(6):404-6. PubMed ID: 2851786
[TBL] [Abstract][Full Text] [Related]
19. Serum prealbumin, transferrin and alpha-1-acid glycoprotein in patients with gynecological carcinomas.
Tosner J; Krejsek J; Louda B
Neoplasma; 1988; 35(4):403-11. PubMed ID: 3141823
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
Novakovic S; Fras PA; Jezersek-Novakovic B
In Vivo; 2001; 15(4):327-32. PubMed ID: 11695225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
